Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-047746
Filing Date
2023-10-11
Accepted
2023-10-11 10:17:14
Documents
1
Period of Report
2023-10-10

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 11702
  Complete submission text file 0001140361-23-047746.txt   13189
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZYNERBA PHARMACEUITCALS, INC. 80 W. LANCASTER AVENUE, SUITE 300 DEVON PA 19333
Business Address
Jones Kenneth T (Reporting) CIK: 0001988882 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37526 | Film No.: 231319744